Tuesday | Azcentral.com
Abraxis Biosciences dedicates its new lab in Phoenix
A Los Angeles-based biotechnology company on Wednesday unveiled a new $70 million Phoenix manufacturing site that will create up to 200 technology jobs.
Watson Pharmaceuticals: Income Statement Analysis for the September 2009 Quarter
Watson Pharmaceuticals, Inc. earned $0.54 per share in the third quarter of 2009, down from $0.60 in the same quarter of last year.
Watson gets boost in Q3 from new product introductions
MORRISTOWN,A N.J. Profits for generic drug maker Watson Pharmaceuticals got a big boost during third quarter 2009, jumping to $76.1 million from third quarter 2008a TMs $54 million, the company announced in an earnings report.
Watson Reports Third Quarter 2009 Gaap Eps of $0.55; Adjusted Eps of $0.66
Watson Pharmaceuticals, Inc. today reported net income of $63.0 million, or $0.55 per diluted share for the third quarter ended September 30, 2009.
Watson 3Q profit falls 11 percent on taxes, costs
Drug developer Watson Pharmaceuticals Inc. said Wednesday its profit fell 11 percent in the third quarter as higher taxes and charges offset a revenue boost.
Corona-based Watson Pharmaceuticals announces $63 million profit
Watson Pharmaceuticals Inc. on Wednesday reported that its profits declined in the third quarter, as the company invested in launching and marketing several new medications.
Earnings Watch: Updates, advisories and surprises
Exxon Mobil Chemical's /quotes/comstock/13*!xom /quotes/nls/xom affiliate TonenGeneral said Wednesday it's launching a 50-50 joint venture with Toray Industries to develop products for the battery separator film business.
Executive Moves: Watson Pharmaceuticals
R. Todd Joyce has been named senior vice president and chief financial officer of Watson Pharmaceuticals , effective immediately.
Watson Pharmaceuticals today announced that R. Todd Joyce has been named Senior Vice President and Chief Financial Officer effective immediately.
Watson and Barr Settle Lawsuit Over Oxytrol
Watson Pharmaceuticals, Inc. , a leading specialty pharmaceutical company, announced today that its subsidiary Watson Laboratories, Inc.
Watson and Barr Settle Lawsuit Over Oxytrol
Watson Pharmaceuticals, Inc., a specialty pharmaceutical company, announced today that its subsidiary Watson Laboratories, Inc.
Analyst Opinion on WPI, DOV, AHT, SD, MVL and SAPE by WallStSense.com
Our analysts have issued complimentary analysis on the following six companies: Watson Pharmaceuticals Inc.
With new layoffs, Carmel manufacturing plant moves closer to closing
The plan to shut the Watson Laboratories plant on Stoneleigh Avenue pushed forward this week as the company announced another round of layoffs.
New Data Suggest that Gelnique (oxybutynin chloride) gel 10% Does Not ...
Watson Pharmaceuticals, Inc. , a leader in generic and specialty branded pharmaceuticals, announced findings of a double-blind study which demonstrate that GELNIQUE was comparable to placebo in its effect on memory tests and other cognitive functions in older healthy adult subjects when compared to immediate release oral oxybutynin treatments.
Former Watson executive returns to co., appointed EVP global brands
MORRISTOWN, N.J. A generic pharmaceutical company has appointed a new executive to its branded drug division.
Retrial of Ala.'s drug overpricing lawsuit delayed
The retrial of Alabama's prescription drug overpricing lawsuit against California-based Watson Pharmaceuticals has been delayed.
Watson appoints Frederick Wilkinson as executive vice president global brands
Most recently, Wilkinson served as president and chief operating officer of Duramed Pharmaceuticals Inc, a subsidiary of Barr Pharmaceuticals Inc.
Watson to Present at the Bank of America Merrill Lynch Global Healthcare Conference
Watson Pharmaceuticals, Inc. , a leading specialty pharmaceutical company, today announced that Paul Bisaro, Watson's president and chief executive officer, will provide an overview and update of the Company's business at the Bank of America Merrill Lynch Global Healthcare Conference on Tuesday, September 15, 2009 at 2:30 p.m. . An archived ...
Lehman shares jump in over-the-counter trading
Whether it's a matter of ignorance or greed, people are still buying General Motors stock, even though the company and the government have warned that the shares will someday be worthless.
Watson receives FDA approval for Plan B generic
MORRISTOWN,A N.J. Watson Pharmaceuticals on Friday announced that its subsidiary, Watson Laboratories, has received approval from the Food and Drug Administration regarding its abbreviated new drug application for levonorgestrel for over-the-counter use in women ages 17 and above, as well as for prescription use in women under the age of 17.
Also on Topix